The “Google” of human genetic variation
News and events
The deal enables Mind the Byte, a pioneer in developing cloud technologies for computational drug design, to secure its leadership on the Spanish market and furthers its plans to become one of the key companies in the industry in Europe
Researchers from GRIB (IMIM-UPF) have analysed the genome of 68 mammals, including our own species
Together, the two companies will provide a broad portfolio of in silico models covering most aspects of virtual drug discovery and development. Prosilico software will now be included in Mind the Byte's SaaS platform and both firms will promote each other's technologies.
20 world leaders in 3D genomics will meet today until Wednesday in Barcelona at the Barcelona BioMed Conference organized by IRB Barcelona and the BBVA Foundation.
A study published by IRB Barcelona in Nature Genetics demonstrates that the error (mutation) surveillance and repair system shows greater efficiency in the protein-coding regions of genes.
A new pedagogical and communicative tool for the youngest audience
The European project "BioS - Digital skills on Computational Biology for Health Professionals" has been awarded with 1 million euro for the period 2018-2020 within the Erasmus+ Sector Skills Alliances in vocational education and training key action.
The Hospital del Mar Medical Research Institute (IMIM) and the Pompeu Fabra University (UPF) have just published a comment in the prestigious journal Nature Reviews Drug Discovery where they explain the excellent results from eTOX, a project that has facilitated a new model for collaboration among pharmaceutical companies, as well as between these and academia, where data and knowledge are shared for the purposes of improving the toxicological evaluation of drugs.
May we inform you that the interuniversity Doctorate Program in Bioinformatics is already running and that preregistration is open until November 15th.